Animalcare Group PLC
LSE:ANCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Animalcare Group PLC
LSE:ANCR
|
UK |
|
CMTSU Liquidation Inc
OTC:CBRI
|
US |
|
Eternal Materials Co Ltd
TWSE:1717
|
TW |
|
Erajaya Swasembada Tbk PT
IDX:ERAA
|
ID |
|
NiSource Inc
NYSE:NI
|
US |
|
Advanced Technology & Materials Co Ltd
SZSE:000969
|
CN |
|
F
|
Fujian Supertch Advanced Material Co Ltd
SSE:688398
|
CN |
|
NGL Energy Partners LP
NYSE:NGL
|
US |
|
C
|
CI Resources Ltd
ASX:CII
|
AU |
|
LCI Industries
NYSE:LCII
|
US |
|
Ashtead Group PLC
LSE:AHT
|
UK |
|
Borqs Technologies Inc
OTC:BRQSF
|
CN |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
G
|
Gama Explorations Inc
CNSX:GAMA
|
CA |
|
InPlay Oil Corp
TSX:IPO
|
CA |
|
AGCO Corp
NYSE:AGCO
|
US |
|
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT
IDX:LSIP
|
ID |
|
K
|
Kaushalya Infrastructure Development Corporation Ltd
NSE:KAUSHALYA
|
IN |
|
Credit Corp Group Ltd
ASX:CCP
|
AU |
|
I
|
Insun Environmental New Technology Co Ltd
KOSDAQ:060150
|
KR |
|
agilon health inc
NYSE:AGL
|
US |
|
ModivCare Inc
NASDAQ:MODV
|
US |
|
Deep Medicine Acquisition Corp
NASDAQ:TRUG
|
US |
Multiples-Based Value
The Multiples-Based Value of one
ANCR
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 226 GBX,
Animalcare Group PLC
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ANCR Competitors Multiples
Animalcare Group PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Animalcare Group PLC
LSE:ANCR
|
155.9m GBP | 1.9 | 52.3 | 12.4 | 32.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |